Brazilian Health Regulator on Jan 29 said that the COVID-19 vaccine developed by AstraZeneca & Oxford University has applied for full regulatory approval. A spokesperson from AstraZeneca has confirmed the submission. The vaccine developer is the main source of the vaccination to Brazil federal government and it has ordered the material to make 100 million doses which will be manufactured by Fiocruz.
Anvisa -Brazilian Health Regulator stated that the period to process authorization of the drug is of 60 days but they will try to shorten the time period. But the authorization will not solve the situation of the slow delivers as the raw material to process further doses has been stuck in Chinese province.
The Brazilian President was in the spotlight after stating that he won’t be taking any vaccination against COVID-19 even after testing positive for the same.